EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells

Cellular Signalling

Volumn 24, Issue 1, 2012, Pages 296-301

  Grøvdal, Lene Melsæther ^a   Kim, Jiyoung ^a   Holst, Mikkel Roland ^a   Knudsen, Stine Louise Jeppe ^a   Grandal, Michael Vibo ^a   van Deurs, Bo ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

EGFR inhibitors; ErbB3; Resistance

Indexed keywords

CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; FAS ANTIGEN; GEFITINIB; KI 67 ANTIGEN; MESSENGER RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; UPREGULATION;

BREAST NEOPLASMS; BUTADIENES; CELL LINE, TUMOR; CHROMONES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMIDAZOLES; MAP KINASE KINASE 1; MORPHOLINES; NITRILES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRIDINES; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RNA, MESSENGER; SIGNAL TRANSDUCTION; TYRPHOSTINS; UP-REGULATION;

EID: 80755133415     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.09.012     Document Type: Article

References (23)

1. Hynes N.E., Lane H.A. Nature Reviews Cancer 2005, 5:341-354.
2. Citri A., Yarden Y. Nature Reviews. Molecular Cell Biology 2006, 7:505-516.
3. Maemondo M., Inoue A., Kobayashi K., Sugawara S., Oizumi S., Isobe H., Gemma A., Harada M., Yoshizawa H., Kinoshita I., Fujita Y., Okinaga S., Hirano H., Yoshimori K., Harada T., Ogura T., Ando M., Miyazawa H., Tanaka T., Saijo Y., Hagiwara K., Morita S., Nukiwa T. The New England Journal of Medicine 2010, 362:2380-2388.
4. Hynes N.E., Macdonald G. Current Opinion in Cell Biology 2009, 21:177-184.
5. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Science 1987, 235:177-182.
6. Moasser M.M., Basso A., Averbuch S.D., Rosen N. Cancer Research 2001, 61:7184-7188.
7. Moulder S.L., Yakes F.M., Muthuswamy S.K., Bianco R., Simpson J.F., Arteaga C.L. Cancer Research 2001, 61:8887-8895.
8. Normanno N., Campiglio M., De L.A., Somenzi G., Maiello M., Ciardiello F., Gianni L., Salomon D.S., Menard S. Annals of Oncology 2002, 13:65-72.
9. Normanno N., De L.A., Maiello M.R., Mancino M., D'Antonio A., Macaluso M., Caponigro F., Giordano A. Frontiers in Bioscience 2005, 10:2611-2617.
10. Citri A., Skaria K.B., Yarden Y. Experimental Cell Research 2003, 284:54-65.
11. Holbro T., Beerli R.R., Maurer F., Koziczak M., Barbas C.F., Hynes N.E. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8933-8938.
12. Engelman J.A., Janne P.A., Mermel C., Pearlberg J., Mukohara T., Fleet C., Cichowski K., Johnson B.E., Cantley L.C. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:3788-3793.
13. Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., Hyland C., Park J.O., Lindeman N., Gale C.M., Zhao X., Christensen J., Kosaka T., Holmes A.J., Rogers A.M., Cappuzzo F., Mok T., Lee C., Johnson B.E., Cantley L.C., Janne P.A. Science 2007, 316:1039-1043.
14. Sergina N.V., Rausch M., Wang D., Blair J., Hann B., Shokat K.M., Moasser M.M. Nature 2007, 445:437-441.
15. Amin D.N., Sergina N., Ahuja D., McMahon M., Blair J.A., Wang D., Hann B., Koch K.M., Shokat K.M., Moasser M.M. Science Translational Medicine 2010, 2. 16ra7.
16. Garrett J.T., Olivares M.G., Rinehart C., Granja-Ingram N.D., Sanchez V., Chakrabarty A., Dave B., Cook R.S., Pao W., McKinely E., Manning H.C., Chang J., Arteaga C.L. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:5021-5026.
17. Wakeling A.E., Guy S.P., Woodburn J.R., Ashton S.E., Curry B.J., Barker A.J., Gibson K.H. Cancer Research 2002, 62:5749-5754.
18. Rho J.K., Choi Y.J., Ryoo B.Y., Na I.I., Yang S.H., Kim C.H., Lee J.C. Cancer Research 2007, 67:1163-1169.
19. Buache E., Etique N., Alpy F., Stoll I., Muckensturm M., Reina-San-Martin B., Chenard M.P., Tomasetto C., Rio M.C. Oncogene 2011.
20. Sheng Q., Liu X., Fleming E., Yuan K., Piao H., Chen J., Moustafa Z., Thomas R.K., Greulich H., Schinzel A., Zaghlul S., Batt D., Ettenberg S., Meyerson M., Schoeberl B., Kung A.L., Hahn W.C., Drapkin R., Livingston D.M., Liu J.F. Cancer Cell 2010, 17:298-310.
21. Schoeberl B., Faber A.C., Li D., Liang M.C., Crosby K., Onsum M., Burenkova O., Pace E., Walton Z., Nie L., Fulgham A., Song Y., Nielsen U.B., Engelman J.A., Wong K.K. Cancer Research 2010, 70:2485-2494.
22. McKillop D., Partridge E.A., Kemp J.V., Spence M.P., Kendrew J., Barnett S., Wood P.G., Giles P.B., Patterson A.B., Bichat F., Guilbaud N., Stephens T.C. Molecular Cancer Therapeutics 2005, 4:641-649.
23. Narayan M., Wilken J.A., Harris L.N., Baron A.T., Kimbler K.D., Maihle N.J. Cancer Research 2009, 69:2191-2194.